Sunscreen tips for a skin smart summer!
25 January 2017
Connie-Lee Swadling, a mother from Queensland, recently posted on Facebook about some advice her doctor gave her regarding sunscreen. The post has since received over 30 thousand likes and has been shared over 40 thousand times. We know that people are talking about it, so we thought it was important that we share some sunscreen tips with the help of Professor Pascale Guitera, Dermatologist Associate for Melanoma Institute Australia.
This is the post circulating Facebook. Source: Facebook
Slather it on
We always recommend buying the highest possible SPF sunscreen (currently SPF50+ in Australia) with broad spectrum UVA and UVB protection, however slapping it on before you head out for the day simply is not enough. You’re most likely not applying the amount actually recommended for adequate protection. As a guide, you need a shot glass full of sunscreen to cover your whole body and face. Most people put less than half the recommended amount of sunscreen on which means they aren’t getting sufficient protection. So if you're wearing only half the recommended amount of SPF 50, you're only getting the protection of SPF 25.
Layer it up
How can you make sure you’re receiving the best possible protection from the sun? Aside from seeking shade and wearing hats, long sleeves and UV-blocking sunglasses, you should be re-applying sunscreen every two hours. This is essential if you’re outside all day long, especially in summer. In addition, if you’ve been swimming or sweating heavily, you should also reapply.
Mix and match
Just like you may use a different face moisturiser for day and night, you can use different types of sunscreens for different purposes. Sunscreen spray may be fine for an early morning jog that you fit in before work but won’t do the job if you’re down at the beach during the day or standing around watching Saturday sports.
These are times when physical sunscreens - that use natural, mineral filters (Titanium Dioxide and Zinc Oxide) to reflect UV rays - should be applied. Physical blockers are preferred for young children’s sensitive skin, and for people who may want to avoid certain ingredients in chemical sunscreens. Generally, the higher the concentration of a physical blocking, the more effective a sunscreen is.
If you do use a sunscreen spray for cooler parts of the day, apply an even, generous coating and don’t forget to layer applications as spray sunscreen isn’t as effective as physical blockers at reflecting light. When applying sunscreen spray, be sure to stay out of the wind!
Make the application of sunscreen part of your daily routine. Your skin is your biggest organ so it is so important that you make every effort possible to protect it.
Australasian Melanoma Conference AMC2021
The 2021 Australasian Melanoma Conference (AMC2021) will held in Sydney, Australia.
Sharing our knowledge of melanoma on the global stage
As leaders in the field of melanoma, clinicians and researchers from MIA will be sharing their knowledge at the virtual 10th World Congress of Melanoma.
Community Fundraising Wrap Up Jan-Mar 2021
The easing of COVID restrictions has meant the return of community events, and we recognise the generous support of our community fundraisers.
Melanoma patients and their families urged to speak up and put national spotlight on melanoma.
Melanoma patients and their carers are being urged to participate in a ground-breaking survey which will shape the future of melanoma treatment, research, support and funding in Australia.
Support for Melanoma March has come from everywhere
We have been buoyed by the wonderful support for our Melanoma March campaign, and our mission to cover Australia in footprints continues into April!
An inspiring WA Melanoma Community Forum
There was a wonderful feeling of community support amongst the melanoma patients, families and friends at the WA Melanoma Community Form.
Family of 8-year-old with melanoma calls on all Australians to step up to help save lives
The Price family has decided to share their story to inspire Australians to support research into new melanoma treatments.
Rethinking skin surveillance for high-risk melanoma patients
New research has provided evidence in favour of a structured skin surveillance program for high-risk melanoma patients.
Australia's oldest melanoma survivor steps up to save lives on his 105th birthday
Melanoma research saved Bert's life at 101 and now he wants to give back.
Predicting disease spread in thin melanoma
A new MIA online risk calculator for clinicians can determine the likelihood of thin melanoma spreading.
Exploring our own clinical questions through MIA's new trials initiative
MIA has recently established a new division of our Clinical Trials Program which co-ordinates and manages investigator-led multi-centre trials.
Young researchers awarded Fellowships to pursue innovative treatments for melanoma
Two young researchers from MIA and The University of Sydney awarded Cancer Institute NSW fellowships.
Young researchers receive boost to develop innovative treatment for melanoma
Two young researchers from MIA and The University of Sydney awarded Cancer Institute NSW fellowships.
Launch of Melanoma March 2021
Aussies urged to leave their footprint on melanoma as efforts step up to save lives from the disease.
Olivia Vivian announced as MIA ambassador
Olivia is using her Ninja star power to shine a spotlight on melanoma prevention - in memory of her dad.
Melanoma breakthrough - neoadjuvant treatment saving lives.
Drug treatment before surgery, known as neoadjuvant therapy, is being hailed as one of the biggest breakthroughs in melanoma treatment since the advent of immunotherapy.
Melanoma breakthrough - neoadjuvant therapy saving lives.
Drug treatment before surgery, known as neoadjuvant therapy, is being hailed as one of the biggest breakthroughs in melanoma treatment since the advent of immunotherapy.
Are cancer patients on immunotherapy at a greater risk of severe COVID-19 infection?
New research, led by MIA, has revealed that cancer patients treated with immunotherapy are not at a higher risk of developing severe COVID-19 infection compared to other cancer patients.
Are cancer patients on immunotherapy at a greater risk of severe COVID-19 infection?
New research, led by MIA, has revealed that cancer patients treated with immunotherapy are not at a higher risk of developing severe COVID-19 infection compared to other cancer patients.
A message to all Australians from melanoma patient Stuart Taylor
Stuart has advanced melanoma which is not responding to treatment. He has shared his story on ABC's 7:30 in the hope that others can escape the same fate.